HANDOK Inc. (KRX:002390)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,760
-80 (-0.68%)
Last updated: Jun 25, 2025
-21.02%
Market Cap 158.56B
Revenue (ttm) 498.45B
Net Income (ttm) -58.00B
Shares Out 13.76M
EPS (ttm) -4,217.28
PE Ratio n/a
Forward PE n/a
Dividend 200.00 (1.74%)
Ex-Dividend Date Feb 27, 2025
Volume 8,412
Average Volume 11,805
Open 11,750
Previous Close 11,840
Day's Range 11,700 - 11,990
52-Week Range 10,500 - 18,960
Beta 0.58
RSI 45.80
Earnings Date Aug 12, 2025

About HANDOK

HANDOK Inc. operates as a pharmaceutical company. The company provides ETC and OTC drugs; and medical devices and research products, including blood pressure monitors, cholesterol monitoring systems, insulin pumps, self monitoring system of blood glucose, and blood glucose monitoring system. It focuses on various therapeutic areas, such as oncology, diabetes and metabolic disorders, CNS, orphan diseases, eye disorders, and other disease areas. The company also offers healthcare products comprising food supplements under the NatureSet brand; foo... [Read more]

Sector Healthcare
Founded 1954
Employees 950
Stock Exchange Korea Stock Exchange
Ticker Symbol 002390
Full Company Profile

Financial Performance

In 2024, HANDOK's revenue was 507.36 billion, a decrease of -2.94% compared to the previous year's 522.74 billion. Losses were -52.56 billion, 82.5% more than in 2023.

Financial Statements

News

There is no news available yet.